Abstract: The disclosed computer-implemented method may include identifying and notifying requestors that may be candidates for a particular autonomous vehicle in order to find those candidates that may be willing or able to relax their travel constraints to match the autonomous vehicle. A request flow may involve surfacing the potential option of matching to an autonomous vehicle before setting a specific destination. For example, the request flow may involve determining that an autonomous vehicle is sufficiently near an in-session potential requestor. Before the potential requestor enters a specific destination, the request flow may present the possibility of the potential requestor being matched with the autonomous vehicle. In some examples, the request flow may then provide available drop-off locations that are compatible with the autonomous vehicle for selection by the potential requestor. Various other methods, systems, and computer-readable media are also disclosed.

Abstract: A method of operating an exoskeleton system that includes obtaining a first set of sensor data from one or more sensors associated with one or more leg actuator units of an exoskeleton system during a user activity, the first set of sensor data indicating a first configuration state of the one or more actuator units; determining, based at least in part on the first set of obtained sensor data, to change configuration of the one or more leg actuator units to a second configuration state to support a user during the user activity; and introducing fluid to one or more fluidic actuators of the one or more leg actuator units to generate the second configuration state by causing the one or more fluidic actuators to apply force at the one or more actuator units.

Abstract: A bone clamp (1, 200, 300) for use in fixation of a fractured bone, or prevention of fracture of a bone, the clamp (1, comprising a pair of handles (2a, 2b) joined together at a pivot point (5), the handles (2a, 2b) each having an arcuate jaw (4a 4b), the arcuate jaws (4a, 4b) comprising a first end (7a, 7b) having an opening at a proximal end (12a, 12b) of the jaw (4a, 4b) in communication with a second end (8a, 8b) having an opening at a distal end (14a, 14b) of the jaw (4a, 4b), the first end (7a, 7b) and second end (8a, 8b) in communication via a channel (6a, 6b), in which the channel (6a, 6b) is configured to accommodate a cable, a wire, a suture, a band or other suitable flexible material, and wherein the channel (6a, 6b) is an open channel.

Abstract: Systems and methods for operating a spark ignition engine that includes a particulate filter in the engine's exhaust system are described. In one example, the spark ignition engine is prevented from exceeding a threshold engine load when the engine is supplying power to an electric machine so that engine emissions may be reduced.

Abstract: A vehicle includes a transmission having an electric machine, a park ring fixedly coupled to the electric machine, and a parking pawl engageable with the park ring to hold the park ring stationary when the transmission is in PARK. A vehicle is programmed to, responsive to a request to shift from PARK, command disengagement of the parking pawl and concurrently command a torque to the electric machine to counteract driveline torque on the park ring.

Abstract: Systems and methods for operating a spark ignition engine that includes a particulate filter in the engine's exhaust system are described. In one example, a threshold temperature at which the spark ignition engine may be automatically stopped is adjusted according to an amount of soot that is stored in the particulate filter.

Abstract: A vehicle includes a transmission having an electric machine, a park ring fixedly coupled to the electric machine, and a parking pawl engageable with the park ring to hold the park ring stationary when the transmission is in PARK. A vehicle is programmed to, responsive to a request to shift from PARK, command disengagement of the parking pawl and concurrently command a torque to the electric machine to counteract driveline torque on the park ring.

Abstract: Systems and methods for operating a spark ignition engine that includes a particulate filter in the engine's exhaust system are described. In one example, a threshold temperature at which the spark ignition engine may be automatically stopped is adjusted according to an amount of soot that is stored in the particulate filter.

Abstract: Systems and methods for operating a spark ignition engine that includes a particulate filter in the engine's exhaust system are described. In one example, the spark ignition engine is prevented from exceeding a threshold engine load when the engine is supplying power to an electric machine so that engine emissions may be reduced.

Abstract: Systems and methods for operating a spark ignition engine that includes a particulate filter in the engine's exhaust system are described. In one example, a threshold temperature at which the spark ignition engine may be automatically stopped is adjusted according to an amount of soot that is stored in the particulate filter.

Abstract: Systems and methods for operating a spark ignition engine that includes a particulate filter in the engine's exhaust system are described. In one example, a threshold temperature at which the spark ignition engine may be automatically stopped is adjusted according to an amount of soot that is stored in the particulate filter.

Abstract: A monitoring and control system, apparatus and method for safe administration, reduction or cessation of administration of at least on medication, fluid or both, which includes at least one Central Source Site (CSS) Photoplethysmography (PPG) sensor coupled to means for control of delivery of the at least one medication, fluid or both.

Abstract: A pharmacodynamic (PD), pharmacokinetic (PK), or both and PK guided infusion device, system and method optimizes the safety and efficacy of various forms of treatment or therapy (e.g., drug and/or fluid) in a variety of health-care and other settings.

Abstract: Devices, systems, and methods are provided for applying a controlled amount of torque during a surgical procedure. In one exemplary embodiment, after the amount of torque applied reaches a threshold amount, a modular driver tip can be deformed, for instance by breaking into pieces. A containment shield disposed around at least a portion of the tip is configured to receive at least a portion of the tip after it is deformed. In one aspect, multiple modular driver tips can be disposed in a cartridge, with a distal-most tip being held by a driver tip holder that has a holding force that is greater than a threshold torque value of the tip. Exemplary methods for operating surgical drivers and systems that include tips that deform at a threshold torque value, and a multitude of embodiments of tools and systems, are also provided.

Abstract: Devices, systems, and methods are provided for applying a controlled amount of torque during a surgical procedure. In one exemplary embodiment, after the amount of torque applied reaches a threshold amount, a modular driver tip can be deformed, for instance by breaking into pieces. A containment shield disposed around at least a portion of the tip is configured to receive at least a portion of the tip after it is deformed. In one aspect, multiple modular driver tips can be disposed in a cartridge, with a distal-most tip being held by a driver tip holder that has a holding force that is greater than a threshold torque value of the tip. Exemplary methods for operating surgical drivers and systems that include tips that deform at a threshold torque value, and a multitude of embodiments of tools and systems, are also provided.

Abstract: A pharmacodynamic (PD), pharmacokinetic (PK), or both and PK guided infusion device, system and method optimizes the safety and efficacy of various forms of treatment or therapy (e.g., drug and/or fluid) in a variety of health-care and other settings.

Abstract: A monitoring and control system, apparatus and method for safe administration, reduction or cessation of administration of at least on medication, fluid or both, which includes at least one Central Source Site (CSS) Photoplethysmography (PPG) sensor coupled to means for control of delivery of the at least one medication, fluid or both.

Abstract: A method to achieve perceived reliability for repairable systems including goal setting of different phases of the product life cycle. The method includes consideration of a plurality of product life cycle phases to determine a plurality of failure rate multipliers which are transformed to mean time between failures multipliers and normalized. Using these computed mean times between failures multipliers and a chosen level of customer use, the box-of-parts required mean time between failures level can be calculated. Also, the required mean time between failures for design, manufacturing, infant mortality, and service phase of product life cycle can be computed.

Abstract: A device for stabilizing traction in a zero turn mower having a riding frame, a pair of front caster-type wheels, a primary right-side rear wheel and a primary left-side rear wheel, and an asymmetric drive system to said rear wheels for driving and steering, comprising: a) auxiliary right-side and left-side rear wheels rotatably mounted on stub axles positioned rearwardly of said primary rear wheels; b) a first rigid member extending between and pivotally coupled to said auxiliary right-side rear wheel and said primary right-side rear wheel; c) a second rigid member extending between and pivotally coupled to said auxiliary left-side rear wheel and said primary left-side rear wheel; d) a first drive coupling member for driving said auxiliary right-side rear wheel in tandem with said primary right-side rear wheel; and e) a second drive coupling member for driving said auxiliary left-side rear wheel in tandem with said primary left-side rear wheel.

Abstract: In accordance with the present invention, there is provided pregabalin lactose conjugate compounds. Also provided as part of the present invention is a novel method of central nervous system disorders or diseases including seizure disorders, pain, depression, anxiety, sleep disorders, consumptive disorders, psychosis, tardive dyskinesia, Huntington's disease, or Parkinson's disease in a subject by administering to the subject a pharmaceutically effective amount of a pregabalin lactose conjugate.